Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(49 sites)
United States
University of Alabama at Birmingham, Birmingham, Alabama USC Norris Cancer Hospital, Los Angeles, California Chao Family Comprehensive Cancer Ctr., Orange, California Yale-New Haven Hospital, New Haven, Connecticut AdventHealth Orlando, Orlando, Florida Florida Cancer Specialists, Sarasota, Florida Indiana Univ Melvin & Bren Simon Cancer Center, Indianapolis, Indiana Community Health Network, Indianapolis, Indiana Mary Bird Perkins Cancer Center, Baton Rouge, Louisiana Massachusetts General Hospital, Boston, Massachusetts Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire NYU Langone Health- Long Island, Mineola, New York NYU Langone, New York, New York Memorial Sloan Kettering Cancer Center, New York, New York The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Novant Health Cancer Institute - Elizabeth, Charlotte, North Carolina Novant Health Cancer Institute - Forsyth, Winston-Salem, North Carolina Fox Chase Cancer Center, Philadelphia, Pennsylvania UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania Sarah Cannon Cancer Center, Nashville, Tennessee Vanderbilt Univeristy School of Medicine, Nashville, Tennessee South Texas Accelerated Research Therapeutics (START), San Antonio, Texas START Mountain Region, West Valley City, Utah Inova Health System IRB, Fairfax, Virginia USO-Virginia Cancer Specialists, PC, Fairfax, Virginia University of Wisconsin-Madison Hospital and Health Clinic, Madison, Wisconsin Australia
Royal North Shore Hospital, St Leonards, New South Wales St Vincent's Hospital Sydney, Sydney, New South Wales Cancer Research SA, Adelaide, South Australia Peninsula and Southeast Oncology, Frankston, Victoria Linear Clinical Research, Nedlands, Western Australia Canada
Cross Cancer Institute, Edmonton, Alberta Princess Margaret Hospital (Ontario), Toronto, Ontario France
Institut Bergonié - Centre Régional de Lutte Contre Le Cancer de Bordeaux et Sud Ouest, Bordeaux, Aquitaine Centre Leon Berard, Lyon, Auvergne-Rhône-Alpes Institut du Cancer de Montpellier - Val d'aurelle, Montpellier Institut Claudius Regaud - IUCT Oncopole, Toulouse Gustave Roussy, Villejuif Japan
Aichi Cancer Center Hospital, Nagoya, Aichi-ken National Cancer Center Hospital East, Kashiwa, Chiba Hokkaido University Hospital, Sapporo, Hokkaido Kanazawa University Hospital, Kanazawa, Ishikawa-ken National Cancer Center Hospital, Chuo-ku, Tokyo Wakayama Medical University Hospital, Wakayama South Korea
National Cancer Center, Goyang-si, Gyeonggi-do The Catholic University of Korea, St. Vincent's Hospital, Suwon, Gyeonggi-do Chonnam National University Hwasun Hospital, Hwasun-gun, Jeonranamdo Seoul National University Hospital, Seoul, Korea Asan Medical Center, Seoul, Korea Last updated September 2025